Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
PPCB
PPCB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PPCB News
Propanc Biopharma Reports H1 2023 Financial Results
Feb 18 2026
seekingalpha
Propanc Publishes Key Findings on PRP's Potential Efficacy Against Pancreatic Cancer
Dec 22 2025
Globenewswire
Propanc Biopharma, Inc. Obtains Up to $100 Million in Private Placement to Enhance Digital Asset Acquisition and Speed Up R&D Initiatives
Nov 10 2025
Newsfilter
Correction: Propanc Biopharma Reveals Strategic Financing Deal Worth Up to $100 Million with Hexstone Capital
Oct 15 2025
Newsfilter
Propanc Shares Key Highlights from Fiscal Year End and Details on Therapeutic Development & $100M+ Digital Asset Treasury Plan
Oct 07 2025
Newsfilter
Propanc Biopharma reveals intention to purchase $100 million in Ethereum
Sep 02 2025
SeekingAlpha
Propanc Biopharma Issues Update for Shareholders
Aug 25 2025
Newsfilter
Rocket Pharmaceuticals Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 20 2025
Benzinga
What’s Happening with Propanc Shares This Monday?
Aug 18 2025
Benzinga
Monday's Major Stock Market Highlights: Morning News Summary
Aug 18 2025
TipRanks
Crude Oil Prices Rise as US Homebuilder Confidence Falls in August
Aug 18 2025
Benzinga
US Stocks Show Varied Performance; Riskified Shares Decline Following Q2 Earnings Report
Aug 18 2025
Benzinga
What’s Behind the 150% Surge in Propanc Biopharma Stock (PPCB) Today?
Aug 18 2025
TipRanks
Dayforce Shares Surge Approximately 21%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 18 2025
Benzinga
Premarket Stock Movements: PPCB, BTAI, TNXP, DAY, TPIC, and Other Notable Gainers and Losers
Aug 18 2025
NASDAQ.COM
Show More News
